Practical Psychopharmacology takes the novel approach of writing at three different levels-beginning, intermediate, and advanced-to give the practicing psychopharmacologist a tailored experience. Each chapter focuses on a specific DSM-5 disorder and outlines abbreviated treatment guidelines to help the reader understand where their knowledge base and clinical practice currently resides. At the first level, the book teaches novice prescribers practical diagnostic skills and provides a brief overview of pertinent genetic and neuroimaging findings to increase prescribing confidence. Next, it provides mid-level clinicians with intermediate techniques and guidelines for more difficult cases. The final level provides nuanced guidance for advanced practitioners or those who see the most treatment-resistant patients. This approach allows a clinician to access this book periodically throughout the care of an individual patient and to gradually progress through a series of more advanced psychopharmacological techniques for making accurate and efficient diagnoses. Readers can also visit the book's eResource page to download a bonus chapter on eating disorders as well as case studies and multiple-choice questions for each chapter.

This updated and revised Second Edition provides a state-of-the-science review and clinical collection of research on treating depression with multiple therapies. The text is an essential guide for those who prescribe psychotropics or perform psychotherapy, including psychiatrists, residents, psychologists, and psychopharmacologists. Containing research data, case studies, and expert recommendations, this source explores the best acute, long-term, and combination treatment strategies for superior patient care.

New to the Second Edition

• a chapter devoted to a simultaneous discussion on psychotherapy and pharmacotherapy
• chapters on depression and anxiety, depression and pain, and new treatment options
• information on the advancements of genetics, imaging, and brain stimulation with regard to depressive disorders and implications for future use
• the latest research on drug development and combining drug treatments

Guiding clinicians toward the most effective treatment regimens, this reference offers detailed coverage of the symptomatology, diagnosis, epidemiology, and etiology of depression. A must-have tool for anyone prescribing psychotropics or performing psychotherapy, this source expertly reviews research and clinical data regarding acute and long-term outcomes, combination therapies, neuroimaging, genetics, and pharmacologic and psychotherapeutic measures to stand as the most complete layout of practices in the management of depression.

Practical Psychopharmacology takes the novel approach of writing at three different levels-beginning, intermediate, and advanced-to give the practicing psychopharmacologist a tailored experience. Each chapter focuses on a specific DSM-5 disorder and outlines abbreviated treatment guidelines to help the reader understand where their knowledge base and clinical practice currently resides. At the first level, the book teaches novice prescribers practical diagnostic skills and provides a brief overview of pertinent genetic and neuroimaging findings to increase prescribing confidence. Next, it provides mid-level clinicians with intermediate techniques and guidelines for more difficult cases. The final level provides nuanced guidance for advanced practitioners or those who see the most treatment-resistant patients. This approach allows a clinician to access this book periodically throughout the care of an individual patient and to gradually progress through a series of more advanced psychopharmacological techniques for making accurate and efficient diagnoses. Readers can also visit the book's eResource page to download a bonus chapter on eating disorders as well as case studies and multiple-choice questions for each chapter.

Following the success of the first collection of Stahl's Case Studies, published in 2011, we are pleased to present this completely new selection of clinical stories. Designed with the distinctive user-friendly presentation readers have become accustomed to and making use of icons, questions/answers and tips, these cases address complex issues in an understandable way and with direct relevance to the everyday experience of clinicians. Covering a wide-ranging and representative selection of clinical scenarios, each case is followed through the complete clinical encounter, from start to resolution, acknowledging all the complications, issues, decisions, twists and turns along the way. The book is about living through the treatments that work, the treatments that fail, and the mistakes made along the journey. This is psychiatry in real life - these are the patients from your waiting room - this book will reassure, inform and guide better clinical decision making. Optional posttests with CME credit are available for a fee (waived for NEI members). For more information, contact the Neuroscience Education Institute.

Since the mid-1990s, a revolution in regards to prescribing antipsychotics has taken place. Once utilized only for schizophrenia, the newer, second generation antipsychotics have now been approved for the treatment of bipolar disorders, depressive disorders, and autism spectrum disorders. They are often utilised elsewhere for the treatment of anxiety disorders, sleep disorders, and to calm agitated patients when dangerous behaviours occur. Prescription rates have soared making them some of the most advertised, prescribed and profitable drugs on the market. This book was developed with input of international authors of varying backgrounds to review the history and development of these agents and to focus on the utilization of these drugs in various disorders, age groups, and clinical situations.